Real stories. Real impact. A better world.
GOOD NEWS DAILY
AllAnimalsCommunityEconomyEnvironmentHealthHumanityInnovationScienceWeekly Recap

Topic

Good news from clinical trials

New drugs, vaccines and devices tested in people, from first safety studies to large phase 3 trials, with the stage and limits of each result stated plainly.

Updated

About this topic

Every new medicine has to pass through clinical trials before it can be approved. Phase 1 studies test safety and dose in 20 to 100 people, phase 2 looks at effect and side effects in up to several hundred, and phase 3 tests real benefit in 300 to 3,000, according to the US Food and Drug Administration. Most drugs drop out along the way: the FDA estimates that about 70% move on from phase 1, about 33% from phase 2 and 25% to 30% from phase 3.

The stories on this page cover trials at every stage. Brazil approved the first human trial of Vivaxin, a vivax malaria vaccine, in 48 healthy adults; a phase 1b trial in Kenya and Zambia found the dose of sevuparin to test in children with severe malaria; an experimental lung cancer drug shrank tumors in 68% of untreated patients in a 60-person phase 1b study; and the UK's AD-SMART trial is testing several Alzheimer's drugs at once against a shared placebo group.

Early results are not proof that a treatment works. In every story we give the trial phase, the number of participants, what was measured and whether the treatment is available anywhere yet, and health stories carry a section on what the news means for patients now.

Each story links to the hospital, university or company behind the trial, and to the paper or trial registry where one exists.

Questions and answers

What are the phases of a clinical trial?
Phase 1 tests safety and dosage in 20 to 100 people, phase 2 tests effect and side effects in up to several hundred, phase 3 tests benefit and monitors adverse reactions in 300 to 3,000, and phase 4 monitors approved drugs in everyday use. (Source: US Food and Drug Administration)
How many drugs make it through trials?
About 70% of drugs move on from phase 1, about 33% from phase 2 and about 25% to 30% from phase 3, according to the FDA. (Source: US Food and Drug Administration)
Do good phase 2 results mean a drug works?
Not yet. The FDA notes that phase 2 studies are usually too small to show whether a drug is beneficial; their job is to add safety data and help design phase 3. (Source: US Food and Drug Administration)
Where can I look up a clinical trial?
ClinicalTrials.gov lists studies from around the world and labels each drug trial with its phase, from Early Phase 1 to Phase 4. (Source: ClinicalTrials.gov)